In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1842 News Items found
Feature
John Mendelsohn
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer

The scientific world lost one of its greats this week. Here, we reflect on his influence.
In the Lab
Illustration of DNA base pairs
What Was MSK’s Role in TCGA, the Groundbreaking Cancer Genomic Study?

The multicenter project, which yielded dozens of scientific papers on more than 30 different kinds of cancer, has officially drawn to a close.
Roundup
2018
Top 10 Stories of 2018, Cancer Research Edition

Take a look back at some of the year’s biggest news in cancer research.
Feature
Vinny as Santa with MSK nurses
Here Comes Santa Claus: How an MSK Locksmith Delivers Joy at Christmas

Every December for almost 30 years, MSK locksmith Vincent “Vinny” Fortunato has dressed up as Santa Claus to spread holiday cheer to patients and their family members.
Feature
Miguel Perales and his patient Jay
How MSK Donors Drive Early Research to Help People with Cancer

Developing new ways to fight cancer is complex. At Memorial Sloan Kettering, patients, doctors, and scientists all participate in research that leads to new discoveries.
In the Lab
electron micrograph of a natural killer cell
Drugs That Stall — But Don’t Kill — Cancer Cells Are an Untapped Resource, Study Suggests

A drug combination that halts tumor cell division can stir the immune system into taking action.
In the Clinic
Kirt Robinson
Kirt’s Story: How a Clinical Trial for a Rare Tumor Gave Me a New Lease on Life

A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.
Targeted Therapy, Sorafenib, Shows Promise as First-Line Treatment for Previously Untreatable Rare Tumors

In patients with progressive, refractory, or symptomatic desmoid tumors, sorafenib (Nexavar®) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective in slowing disease progression.
Feature
MSK patient Dario Cortes
How Rectal Cancer Taught Dario Resilience

Meet Dario Cortes, who was treated for rectal cancer at Memorial Sloan Kettering and is now back to doing the activities he loves.
In the Lab
Illustration of mechanical arms altering a cell
MSK Scientists Fine-Tune CAR T Cells to Improve Their Performance

The updated versions can survive longer in the body while still packing a punch against cancer.